Crohn's disease and colorectal malignancy.

Area of Science:

• Gastroenterology
• Oncology
• Pathology

Background:

• The association between inflammatory bowel disease (IBD) and colorectal cancer (CRC) has been debated for decades.
• Historically, widespread ulcerative colitis was considered the primary risk factor for CRC in IBD patients.
• Recent evidence challenges this notion, suggesting a comparable risk in Crohn's disease (CD) with similar extent and duration.

Observation:

• This case report highlights key clinical and pathological features of Crohn's disease-associated colorectal carcinoma (CDAC).
• It underscores the evolving understanding of CRC risk within different IBD subtypes.
• The presentation emphasizes the need for vigilance in diagnosing colorectal cancer in CD patients.

Findings:

• Evidence suggests Crohn's disease involving the colon carries a similar risk of colorectal carcinoma as ulcerative colitis of comparable extent and duration.
• Crohn's disease-associated colorectal carcinoma (CDAC) presents unique clinical and pathological characteristics.
• The incidence of CRC in CD may be underestimated compared to previous assumptions.

Implications:

• Regular colonic surveillance in patients with Crohn's disease affecting the colon is critical.
• Clinical and pathological awareness of CDAC is essential for timely diagnosis and management.
• This shifts the paradigm in CRC risk assessment for inflammatory bowel disease patients.